Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 53.35
-0.10 (-0.19%)
Jan 2, 2026, 3:55 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 15.75 billion as of December 31, 2025. Its market cap has increased by 40.04% in one year.
Market Cap
15.75B
Enterprise Value
13.64B
Revenue
955.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
53.35
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 15.75B, a decrease of -14.55%. That is a compound annual growth rate of -3.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | 18.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 261.67B |
| Hansoh Pharmaceutical Group Company | 218.43B |
| JD Health International | 178.11B |
| Innovent Biologics | 131.21B |
| WuXi Biologics | 129.79B |
| Sino Biopharmaceutical | 110.48B |
| Akeso | 104.09B |
| CSPC Pharmaceutical Group | 96.38B |